Intraprocedural thrombotic events: What's the real cost?.
Citation: Catheterization & Cardiovascular Interventions. 86(1):40-1, 2015 Jul.PMID: 26097054Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Comment | EditorialSubject headings: *Acute Coronary Syndrome/su [Surgery] | *Hospital Costs | *Intraoperative Complications/ec [Economics] | *Percutaneous Coronary Intervention/ae [Adverse Effects] | *Thrombosis/ec [Economics] | Female | Humans | MaleYear: 2015Local holdings: Available online from MWHC library: 1996 - present, Available in print through MWHC library: 1996 - 2006ISSN:- 1522-1946
Item type | Current library | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | 26097054 | Available | 26097054 |
Available online from MWHC library: 1996 - present, Available in print through MWHC library: 1996 - 2006
Intraprocedural thrombotic events (IPTE) during PCI occur in 4% of patients with NSTEACS and 12% of STEACS. IPTE increases hospital cost by ,592. With an incidence of 4%, additional therapy to completely prevent IPTE in 100 patients would need to cost
English